Roivant Sciences Gain (Loss) on Fair Value of Debt and Liability Instruments increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $14.12M to $0.00. Over 2 years (FY 2021 to FY 2025), Gain (Loss) on Fair Value of Debt and Liability Instruments shows a downward trend with a 277.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A gain may indicate a decrease in the fair value of liabilities, potentially due to changes in market interest rates or credit spreads.
This represents the non-cash gain or loss resulting from changes in the fair value of debt instruments or other liabilit...
Found in companies with complex capital structures or convertible debt instruments.
operating_gain_loss_on_fair_value_of_debt_and_liability__77f897| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.59M | -$13.15M | -$23.02M | $44.10M | -$41.21M | $13.54M | -$62.36M | -$54.51M | -$21.53M | -$9.33M | $0.00 | $118.20M | $14.12M | -$2.33M | -$20.96M | -$24.42M | $0.00 |
| QoQ Change | — | -186.7% | -75.1% | +291.6% | -193.5% | +132.9% | -560.5% | +12.6% | +60.5% | +56.7% | +100.0% | — | -88.1% | -116.5% | -799.9% | -16.5% | +100.0% |
| YoY Change | — | — | — | — | -798.9% | +203.0% | -170.9% | -32.3% | -259.0% | +85.0% | — | +316.8% | — | -102.0% | — | — | -100.0% |